Topic: Seizure, bipolar meds double risk of suicidal symptoms 

A spokesman for Pfizer, Jack Cox, said its review of Neurontin and Lyrica found “no evidence of an increased risk of suicide-related events in either product.”

So are they saying the FDA is lying?

A spokeswoman for GlaxoSmithKline, Mary Anne Rhyne, said its analysis of clinical trials of Lamictal found “general trends that were similar to those seen in the F.D.A. analysis.”

Let's hope they included that bit in their drug ads.

Sandy Walsh, FDA spokesperson, declined commenting on label changes. "Those discussions will take place between the F.D.A. and the drug manufacturers,” she said.

We know what drug companies are saying. Will they listen to consumers?

 [ send green star]

 [ accepted]

Pharma Not in Business of Health, Healing, Cures, Wellness http://www.youtube.com/watch?v=AazObF_pHSU For every dollar spent on "research and development".... 3 dollars is spent on "advertising". There are over 1200 registered drug company lobbyists on Capital Hill. To get a drug approved by the FDA, you have to submit the results of 2 clinical trials that show your drug works better than a placebo. You do not have to report the findings of a trial that you stopped because too many people were dying in it. You just have to report the completed trials. Even then... you can have 100 failures and 2 "successes" to get your drug approved. As long as the money coming in exceeds the money going out, drug companies are doing what they intend to do. And they do it well... Drug company profits are 3 times higher than the other Fortune 500 companies.

 [ accepted]